GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioinfra Co Ltd (XKRX:199730) » Definitions » Treasury Stock

Bioinfra Co (XKRX:199730) Treasury Stock : ₩0 Mil (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bioinfra Co Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Bioinfra Co's treasury stock for the quarter that ended in Sep. 2024 was ₩0 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.


Bioinfra Co Treasury Stock Historical Data

The historical data trend for Bioinfra Co's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioinfra Co Treasury Stock Chart

Bioinfra Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Treasury Stock
- - - -

Bioinfra Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bioinfra Co Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.


Bioinfra Co Business Description

Traded in Other Exchanges
N/A
Address
120 Heungdeokjungang-ro, 4th and 5th Floors, Giheung-gu, Yongin-si, Gyeonggi-do, KOR, 16950
Bioinfra Co Ltd is engaged in the research and experimental development on medical sciences and pharmacy.

Bioinfra Co Headlines

No Headlines